Cloetta AB ser. B (0N7X)

London


	Symbol		Exchange		Currency
	CLOEb		Stockholm		SEK	Real-time
	CLABs		BATS Europe		SEK	Delayed
	CLOEF		OTC Markets		USD	Delayed
	0N7X		London		SEK	Real-time

Currency in SEK

Disclaimer

24.57

+0.14(+0.57%)

Closed01:35:59

Fair Value

Day's Range

24.52

24.64

52 wk Range

16.07

24.64

0N7X Income Statement

Featured here, the Income Statement (earnings report) for Cloetta AB ser. B, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

6,493

5,695

6,046

6,869

8,301

Total Revenues Growth

+4.42%

-12.29%

+6.16%

+13.61%

+20.85%

Cost Of Revenues

4,112

3,699

3,899

4,528

5,703

Gross Profit

2,381

1,996

2,147

2,341

2,598

Gross Profit Growth

+4.38%

-16.17%

+7.57%

+9.04%

+10.98%

Gross Profit Margin %

36.67%

35.05%

35.51%

34.08%

31.3%

Other Operating Expenses, Total

1,647

1,506

1,581

1,654

1,808

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+2.04%	-8.56%	+4.98%	+4.62%	+9.31%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,647	1,506	1,581	1,654	1,808
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

734

490

566

687

790

Operating Income Growth

+10.04%

-33.24%

+15.51%

+21.38%

+14.99%

EBIT Margin %

11.3%

8.6%

9.36%

10%

9.52%

Net Interest Expenses

-35

-33

-29

11

-191

Net Interest Expenses Growth

+46.97%

+5.71%

+12.12%

+137.93%

-1,836.36%

Interest Expense, Total

-35

-33

-29

11

-191

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

-33

-19

27

-130

35

EBT, Excl. Unusual Items

666

438

564

568

634

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-18

-55

-

-225

-

EBT, Incl. Unusual Items

648

383

558

343

570

EBT, Incl. Unusual Items Growth

+15.3%

-40.9%

+45.69%

-38.53%

+66.18%

EBT, Incl. Unusual Items Margin

9.98

6.73

9.23

4.99

6.87

Income Tax Expense

150

118

86

68

133

Net Income to Company

498

265

472

275

437

Minority Interest

-

-

-

-

-

Net Income

498

265

472

275

437

Net Income Growth

+3.11%

-46.79%

+78.11%

-41.74%

+58.91%

Net Income Margin %

7.67%

4.65%

7.81%

4%

5.26%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

498

265

472

275

437

Basic EPS - Continuing Operations

1.74

0.92

1.64

0.96

1.53

Basic EPS - Continuing Operations Growth

+3.07%

-46.79%

+77.56%

-41.6%

+59.69%

Diluted EPS - Continuing Operations

1.74

0.92

1.64

0.96

1.53

Diluted EPS - Continuing Operations Growth

+3.44%

-47.06%

+78.26%

-41.53%

+59.57%

Basic Weighted Average Shares Outstanding

286.58

286.59

287.48

286.81

285.39

Diluted Weighted Average Shares Outstanding

286.72

286.81

287.52

286.89

285.65

Dividend Per Share

0.5

0.75

1

1

1

Dividend Per Share Growth

-50%

+50%

+33.33%

0%

0%

EBITDA

927

675

742

870

987

EBITDA Growth

+7.42%

-27.18%

+9.93%

+17.25%

+13.45%

EBITDA Margin %

14.28%

11.85%

12.27%

12.67%

11.89%

EBIT